Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 5/2010

Open Access 01-10-2010 | Original Article

Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency

Authors: L. Henneman, M. S. Schneiders, M. Turkenburg, H. R. Waterham

Published in: Journal of Inherited Metabolic Disease | Issue 5/2010

Login to get access

Abstract

Mevalonate kinase deficiency (MKD) is an autoinflammatory disorder caused by mutations in the MVK gene resulting in decreased activity of the enzyme mevalonate kinase (MK). Although MK is required for biosynthesis of all isoprenoids, in MKD, in particular, the timely synthesis of geranylgeranyl pyrophosphate appears to be compromised. Because small guanosine triphosphatases (GTPases) depend on geranylgeranylation for their proper signaling function, we studied the effect of MK deficiency on geranylgeranylation and activation of the two small GTPases, RhoA and Rac1. We demonstrate that both geranylgeranylation and activation of the two GTPases are more easily disturbed in MKD cells than in control cells when the flux though the isoprenoid biosynthesis pathway is suppressed by low concentrations of simvastatin. The limited capacity of geranylgeranylation in MKD cells readily leads to markedly increased levels of nonisoprenylated and activated GTPases, which will affect proper signaling by these GTPases.
Literature
go back to reference Ando S, Kaibuchi K, Sasaki T et al (1992) Post-translational processing of rac p21s is important both for their interaction with the GDP/GTP exchange proteins and for their activation of NADPH oxidase. J Biol Chem 267:25709–25713PubMed Ando S, Kaibuchi K, Sasaki T et al (1992) Post-translational processing of rac p21s is important both for their interaction with the GDP/GTP exchange proteins and for their activation of NADPH oxidase. J Biol Chem 267:25709–25713PubMed
go back to reference Bustelo XR, Sauzeau V, Berenjeno IM (2007) GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays 29:356–370CrossRefPubMed Bustelo XR, Sauzeau V, Berenjeno IM (2007) GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays 29:356–370CrossRefPubMed
go back to reference Carlucci F, Rosi F, Di PC, Marinello E, Pizzichini M, Tabucchi A (1997) Purine nucleotide metabolism: specific aspects in chronic lymphocytic leukemia lymphocytes. Biochim Biophys Acta 1360:203–210PubMed Carlucci F, Rosi F, Di PC, Marinello E, Pizzichini M, Tabucchi A (1997) Purine nucleotide metabolism: specific aspects in chronic lymphocytic leukemia lymphocytes. Biochim Biophys Acta 1360:203–210PubMed
go back to reference Frenkel J, Rijkers GT, Mandey SH et al (2002) Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 46:2794–2803CrossRefPubMed Frenkel J, Rijkers GT, Mandey SH et al (2002) Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 46:2794–2803CrossRefPubMed
go back to reference Gibson KM, Hoffmann G, Schwall A et al (1990) 3-Hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured fibroblasts from patients with mevalonate kinase deficiency: differential response to lipid supplied by fetal bovine serum in tissue culture medium. J Lipid Res 31:515–521PubMed Gibson KM, Hoffmann G, Schwall A et al (1990) 3-Hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured fibroblasts from patients with mevalonate kinase deficiency: differential response to lipid supplied by fetal bovine serum in tissue culture medium. J Lipid Res 31:515–521PubMed
go back to reference Hoffmann GF, Charpentier C, Mayatepek E et al (1993) Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics 91(5):915–21 Hoffmann GF, Charpentier C, Mayatepek E et al (1993) Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics 91(5):915–21
go back to reference Hoffmann GF, Wiesmann UN, Brendel S, Keller RK, Gibson KM (1997) Regulatory adaptation of isoprenoid biosynthesis and the LDL receptor pathway in fibroblasts from patients with mevalonate kinase deficiency. Pediatr Res 41:541–546CrossRefPubMed Hoffmann GF, Wiesmann UN, Brendel S, Keller RK, Gibson KM (1997) Regulatory adaptation of isoprenoid biosynthesis and the LDL receptor pathway in fibroblasts from patients with mevalonate kinase deficiency. Pediatr Res 41:541–546CrossRefPubMed
go back to reference Houten SM, Frenkel J, Rijkers GT, Wanders RJ, Kuis W, Waterham HR (2002) Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. Hum Mol Genet 11:3115–3124CrossRefPubMed Houten SM, Frenkel J, Rijkers GT, Wanders RJ, Kuis W, Waterham HR (2002) Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. Hum Mol Genet 11:3115–3124CrossRefPubMed
go back to reference Houten SM, Frenkel J, Waterham HR (2003a) Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation. Cell Mol Life Sci 60:1118–1134PubMed Houten SM, Frenkel J, Waterham HR (2003a) Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation. Cell Mol Life Sci 60:1118–1134PubMed
go back to reference Houten SM, Schneiders MS, Wanders RJ, Waterham HR (2003b) Regulation of isoprenoid/cholesterol biosynthesis in cells from mevalonate kinase-deficient patients. J Biol Chem 278:5736–5743CrossRefPubMed Houten SM, Schneiders MS, Wanders RJ, Waterham HR (2003b) Regulation of isoprenoid/cholesterol biosynthesis in cells from mevalonate kinase-deficient patients. J Biol Chem 278:5736–5743CrossRefPubMed
go back to reference Mandey SH, Kuijk LM, Frenkel J, Waterham HR (2006) A role for geranylgeranylation in interleukin-1beta secretion. Arthritis Rheum 54:3690–3695CrossRefPubMed Mandey SH, Kuijk LM, Frenkel J, Waterham HR (2006) A role for geranylgeranylation in interleukin-1beta secretion. Arthritis Rheum 54:3690–3695CrossRefPubMed
go back to reference Medley QG, Serra-Pages C, Iannotti E et al (2000) The trio guanine nucleotide exchange factor is a RhoA target Binding of RhoA to the trio immunoglobulin-like domain. J Biol Chem 275:36116–36123CrossRefPubMed Medley QG, Serra-Pages C, Iannotti E et al (2000) The trio guanine nucleotide exchange factor is a RhoA target Binding of RhoA to the trio immunoglobulin-like domain. J Biol Chem 275:36116–36123CrossRefPubMed
go back to reference Molnar G, Dagher MC, Geiszt M, Settleman J, Ligeti E (2001) Role of prenylation in the interaction of Rho-family small GTPases with GTPase activating proteins. Biochemistry 40:10542–10549CrossRefPubMed Molnar G, Dagher MC, Geiszt M, Settleman J, Ligeti E (2001) Role of prenylation in the interaction of Rho-family small GTPases with GTPase activating proteins. Biochemistry 40:10542–10549CrossRefPubMed
go back to reference Reid T, Furuyashiki T, Ishizaki T et al (1996) Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the rho-binding domain. J Biol Chem 271:13556–13560CrossRefPubMed Reid T, Furuyashiki T, Ishizaki T et al (1996) Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the rho-binding domain. J Biol Chem 271:13556–13560CrossRefPubMed
go back to reference Sander EE, van Delft S, ten Klooster JP et al (1998) Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J Cell Biol 143:1385–1398CrossRefPubMed Sander EE, van Delft S, ten Klooster JP et al (1998) Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J Cell Biol 143:1385–1398CrossRefPubMed
go back to reference Schneiders MS, Houten SM, Turkenburg M, Wanders RJ, Waterham HR (2006) Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency. Arthritis Rheum 54:2306–2313CrossRefPubMed Schneiders MS, Houten SM, Turkenburg M, Wanders RJ, Waterham HR (2006) Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency. Arthritis Rheum 54:2306–2313CrossRefPubMed
go back to reference Simon A, Drewe E, van der Meer JW et al (2004) Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 75:476–483CrossRefPubMed Simon A, Drewe E, van der Meer JW et al (2004) Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 75:476–483CrossRefPubMed
go back to reference Takai Y, Sasaki T, Matozaki T (2001) Small GTP-binding proteins. Physiol Rev 81:153–208PubMed Takai Y, Sasaki T, Matozaki T (2001) Small GTP-binding proteins. Physiol Rev 81:153–208PubMed
Metadata
Title
Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency
Authors
L. Henneman
M. S. Schneiders
M. Turkenburg
H. R. Waterham
Publication date
01-10-2010
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 5/2010
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9173-8

Other articles of this Issue 5/2010

Journal of Inherited Metabolic Disease 5/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.